MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
12.79
-0.04
-0.31%
After Hours: 12.49 -0.3 -2.37% 17:15 01/16 EST
OPEN
12.83
PREV CLOSE
12.83
HIGH
13.00
LOW
12.55
VOLUME
5.94M
TURNOVER
--
52 WEEK HIGH
16.18
52 WEEK LOW
4.720
MARKET CAP
1.65B
P/E (TTM)
-14.4080
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NEO last week (0112-0116)?
Weekly Report · 20h ago
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and NeoGenomics (NEO)
TipRanks · 01/13 01:20
NeoGenomics: Solid Execution and Clean Quarter Support Fair Valuation, Justifying Hold Amid CFO Transition and Limited Medium-Term Visibility
TipRanks · 01/13 01:15
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 01/13 01:10
NeoGenomics Price Target Maintained With a $14.00/Share by Needham
Dow Jones · 01/12 15:43
Needham Reiterates Buy on NeoGenomics, Maintains $14 Price Target
Benzinga · 01/12 15:32
Insiders Buy the Holdings of FHLC ETF
NASDAQ · 01/12 15:29
NeoGenomics sees Q4 revenue of about $190M
Seeking Alpha · 01/12 12:40
More
About NEO
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.